Temozolomide-d
Cat. No.：YN280172
| 产品名称: | Temozolomide-d |
| CAS No.: | 2130033-55-3 |
| Chemical Name: | 9-(1,3-benzodioxol-5-yl)-6,7-dimethoxy-4-[[3,4-O-(1-methylethylidene)-β-D-galactopyranosyl]oxy]-naphtho[2,3-c]furan-1(3H)-one |
| Synonyms: | |
| 分子量: | 582.552 |
| 分子式: | C30H30O12 |
| SMILES: | O=C1C2=C(C3=CC=C(OCO4)C4=C3)C5=CC(OC)=C(OC)C=C5C(O[C@H]6[C@@H]([C@]7([H])[C@](OC(C)(O7)C)([H])[C@H](O6)CO)O)=C2CO1 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | PHY34 一种抑制ATP6V0A2和CAS进而抑制自噬 (autophagy) 的抑制剂，并具有纳摩尔效应。 PHY34通过诱导凋亡 (apoptosis) 抑制癌细胞生长并抑制荷瘤模型中肿瘤生长。PHY34 用于高级别浆液卵巢癌的研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Young, A.N., Herrera, D., Huntsman, A.C., et al.Phyllanthusmin derivatives induce apoptosis and reduce tumor burden in high-grade serous ovarian cancer by late-stage autophagy inhibitionMol. Cancer Ther.17(10),2123-2135(2018)
